SPONSOR
858 Therapeutics, Inc.
Total Trials
1
Recruiting
1
Phases
Phase 1, Phase 2
Conditions studied: Advanced or Metastatic Solid TumorsBreast CancerOvarian CancerProstate CancerEpithelial Ovarian CancerBRCA2 MutationER+ Breast CancerCastrate Resistant Prostate CancerBRCA1 MutationBRCA Mutation
858 Therapeutics, Inc. is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Advanced or Metastatic Solid Tumors, Breast Cancer, Ovarian Cancer, Prostate Cancer.
The trial portfolio spans Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — 858 Therapeutics, Inc.
How many clinical trials has 858 Therapeutics, Inc. sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by 858 Therapeutics, Inc., of which 1 are actively recruiting participants. These trials cover conditions including Advanced or Metastatic Solid Tumors, Breast Cancer, Ovarian Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does 858 Therapeutics, Inc. research focus on?
858 Therapeutics, Inc. clinical trials span Advanced or Metastatic Solid Tumors, Breast Cancer, Ovarian Cancer, Prostate Cancer, Epithelial Ovarian Cancer, and additional conditions. The research pipeline includes Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a 858 Therapeutics, Inc. clinical trial?
To participate in a 858 Therapeutics, Inc. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all 858 Therapeutics, Inc. trials with current recruitment status updated daily.
Clinical Trials by 858 Therapeutics, Inc.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology